Two to six companies, their latest annual figures side by side, from SEC filings.
| Figure | LCTXLineage Cell Therapeutics, Inc.FY2025 · Dec |
|---|---|
| Revenue | $14.56M |
| Revenue, yoy | +53.2% |
| Net income | $63.53M |
| Net income, yoy | −241.4% |
| Net margin | -436.5% |
| Free cash flow | $19.44M |
| FCF margin | -133.6% |
| EPS, diluted | $0.28 |
Add another company.